E
Eugenia Piliotis
Researcher at Sunnybrook Health Sciences Centre
Publications - 20
Citations - 473
Eugenia Piliotis is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Rituximab & Follicular lymphoma. The author has an hindex of 8, co-authored 20 publications receiving 440 citations.
Papers
More filters
Journal ArticleDOI
Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors
TL;DR: Views on routine follow-up of adult cancer survivors and modalities to facilitate PCPs in providing this care were determined and insights gained may ultimately help guide strategies in providing optimal care to these patients.
Journal ArticleDOI
Evaluation of direct medical costs of hospitalization for febrile neutropenia
Nina Lathia,Nina Lathia,Nicole Mittmann,Nicole Mittmann,Carlo DeAngelis,Carlo DeAngelis,Sandra R. Knowles,Matthew C. Cheung,Eugenia Piliotis,Neil H. Shear,Scott E. Walker,Scott E. Walker +11 more
TL;DR: Treatment of febrile neutropenia is costly, because it typically involves hospitalization and as cancer rates continue to increase, the number of patients suffering from FN will also increase, making it important to quantify the costs.
Journal Article
Macrophage activation syndrome after etanercept treatment.
Journal ArticleDOI
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis
Lee Mozessohn,Matthew C. Cheung,Michael Crump,Rena Buckstein,Neil L. Berinstein,Kevin Imrie,John Kuruvilla,Eugenia Piliotis,Vishal Kukreti +8 more
TL;DR: Patients with CIR resistance had high rates of histologic transformation and shorter survival with poor response to next therapy, compared with patients who received rituximab combination therapy for symptomatic FL.
Journal ArticleDOI
Iron Overload and Haematopoiesis in MDS: Does Blood Transfusion Promote Progression to AML?
Lap Shu Alan Chan,Rena Buckstein,Marciano D. Reis,Alden Chesney,Adam Lam,Matthew C. Cheung,Eugenia Piliotis,Lilly Chunhong Gu,Richard A. Wells +8 more
TL;DR: These results establish a relationship between CD34+ cell ROS content and serum ferritin concentration in MDS patients with iron overload, and indicate that iron chelation therapy in this patient population reverses this ROS accumulation.